CESAR
MORIS DE LA TASSA
Catedrático de Universidad
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (11)
2021
-
Scoring balloon predilation before bioresorbable vascular scaffold implantation in patients with in-stent restenosis: the RIBS VI 'scoring' study
Coronary artery disease, Vol. 32, Núm. 2, pp. 96-104
2020
-
Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: A real-life propensity-score matched study
Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-14
2019
-
Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement
Journal of the American College of Cardiology, Vol. 74, Núm. 5, pp. 631-641
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
-
The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacement
European Journal of Health Economics, Vol. 19, Núm. 7, pp. 945-956
2017
-
Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study
JACC: Cardiovascular Interventions, Vol. 10, Núm. 18, pp. 1841-1851
-
Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)
American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990
2016
-
Comparison of the Efficacy of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients with In-Stent Restenosis (from the RIBS IV and v Randomized Clinical Trials)
American Journal of Cardiology, Vol. 117, Núm. 4, pp. 546-554
2015
-
Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)
EuroIntervention, Vol. 11, Núm. 3, pp. 336-342
-
Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: Cost-utility and its determinants
International Journal of Cardiology, Vol. 182, pp. 321-328
2013
-
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011
Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958